Chemosensitivity-Gene Expression Correlations and Functional Enrichment Analysis Provide Insight into the Mechanism...

Area of Science:

• Molecular Pharmacology
• Cancer Biology
• Computational Biology

Background:

• Anticancer drug development requires understanding precise mechanisms of action.
• Distinguishing novel agents from established chemotherapies is crucial for optimizing treatment strategies.
• The nucleolus is increasingly recognized as a potential target for cancer therapy.

Purpose of the Study:

• To elucidate the mechanistic differences between a nucleolus-targeting platinum-acridine agent (PA) and conventional DNA-directed chemotherapies.
• To investigate the role of DNA repair and RNA processing pathways in cellular response to PA.
• To identify functional interactions between cellular pathways involved in response to nucleolar stress.

Main Methods:

• Analysis of NCI-60 cell line growth inhibition data.
• Gene expression profiling using Pearson correlation and functional enrichment analysis.
• Computational modeling to identify pathway interactions.

Main Results:

• PA's potency negatively correlates with DNA double-strand break (DSB) repair gene expression, supporting DNA as a primary target.
• Genes involved in RNA processing and ribosome biogenesis are negatively enriched, suggesting resistance mechanisms.
• Oxaliplatin and other DNA-targeted drugs show opposite trends compared to PA.
• Functional interactions identified between ribosome biogenesis and DSB repair pathways, including the RPL5-MDM2-p53 pathway, in response to nucleolar stress.

Conclusions:

• The platinum-acridine agent exhibits a unique anticancer mechanism involving DNA targeting and induction of nucleolar stress.
• Ribosome biogenesis and DNA repair pathways modulate cellular sensitivity to this novel agent.
• Understanding these pathway interactions provides insights into resistance mechanisms and potential therapeutic strategies.